08 July 2024 : Clinical Research
Optimal Surgical Approaches for Thyroid Cancer: A Comparative Analysis of Efficacy and Complications
Abbas Aras
1ABDEF*, Ali R. Karayıl 2BCG
DOI: 10.12659/MSM.942619
Med Sci Monit 2024; 30:e942619
Table 1 Summary of patient and tumor characteristics with regard to pathology results in the completion thyroidectomy (CTx-HTx) after hemithyroidectomy group.
| Total (n=60) | Pathology result, CTx surgery | P | ||
|---|---|---|---|---|
| CTx-B (n=46) | CTx-M (n=14) | |||
| Age | 39.38±13.12 | 38.96±11.85 | 40.79±17.10 | 0.652 |
| ≤45 | 43 (71.7%) | 33 (71.7%) | 10 (71.4%) | 1.000 |
| >45 | 17 (28.3%) | 13 (28.3%) | 4 (28.6%) | |
| Sex | ||||
| Female | 46 (76.7%) | 36 (78.3%) | 10 (71.4%) | 0.720 |
| Male | 14 (23.3%) | 10 (21.7%) | 4 (28.6%) | |
| Thyroid cancer history in family | 8 (13.3%) | 6 (13.0%) | 2 (14.3%) | 1.000 |
| Tumor size* | ||||
| <1 cm | 5 (9.4%) | 4 (9.3%) | 1 (10.0%) | 0.996 |
| 1–4 cm | 37 (69.8%) | 30 (69.8%) | 7 (70.0%) | |
| >4 cm | 11 (20.8%) | 9 (20.9%) | 2 (20.0%) | |
| Capsular invasion* | 26 (49.1%) | 21 (48.8%) | 5 (50.0%) | 1.000 |
| Vascular invasion* | 8 (15.1%) | 7 (16.3%) | 1 (10.0%) | 1.000 |
| Extrathyroidal invasion* | 7 (13.2%) | 5 (11.6%) | 2 (20.0%) | 0.604 |
| Multicentric* | 10 (18.9%) | 7 (16.3%) | 3 (30.0%) | 0.376 |
| Lymph node metastasis* | 4 (7.5%) | 3 (7.0%) | 1 (10.0%) | 1.000 |
| Thyroglobulin* | ||||
| <30 ng/mL | 53 (93.0%) | 42 (93.3%) | 11 (91.7%) | 1.000 |
| ≥30 ng/mL | 4 (7.0%) | 3 (6.7%) | 1 (8.3%) | |
| Pathology result, 1 surgery | ||||
| Papillary thyroid carcinoma | 51 (85.0%) | 39 (84.8%) | 12 (85.7%) | 0.981 |
| Papillary microcarcinoma | 5 (8.3%) | 4 (8.7%) | 1 (7.1%) | |
| Follicular thyroid carcinoma | 4 (6.7%) | 3 (6.5%) | 1 (7.1%) | |
| Time between surgeries, days | 61 (14–207) | 60.5 (28–116) | 64 (14–207) | 0.421 |
| 10–90 days | 51 (85.0%) | 41 (89.1%) | 10 (71.4%) | 0.193 |
| >90 days | 9 (15.0%) | 5 (10.9%) | 4 (28.6%) | |
| Side, 2 surgery | ||||
| Right | 23 (38.3%) | 19 (41.3%) | 4 (28.6%) | 0.586 |
| Left | 37 (61.7%) | 27 (58.7%) | 10 (71.4%) | |
| Data are given as mean±standard deviation or median (minimum-maximum) for continuous variables according to normality of distribution and as frequency (percentage) for categorical variables. * There are missing data. CTx – completion thyroidectomy; CTx-B – patients with benign pathology according to the completion thyroidectomy specimen; CTx-M – patients with malign pathology according to the completion thyroidectomy specimen. | ||||